New patent for Biogen Idec drug SPINRAZA

Annual Drug Patent Expirations for SPINRAZA Spinraza is a drug marketed by Biogen Idec and is included in one NDA. It is available from one supplier. There are eight patents…

Source


Comments are closed.

Biotechblog